Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/51753

Registo completo
Campo DCValorIdioma
dc.contributor.authorLoureiro, Ana Isabel Sápor
dc.contributor.authorJennifer Noropor
dc.contributor.authorAbreu, Ana S.por
dc.contributor.authorNogueira, E.por
dc.contributor.authorSoares da Costa, Dianapor
dc.contributor.authorSilva, Carlapor
dc.contributor.authorCavaco-Paulo, Arturpor
dc.date.accessioned2018-03-07T19:19:43Z-
dc.date.available2018-03-07T19:19:43Z-
dc.date.issued2018-02-
dc.identifier.citationLoureiro, Ana; Jennifer Noro; Abreu, Ana S.; Nogueira, E.; Soares da Costa, Diana; Silva, Carla; Cavaco-Paulo, Artur, The absence of albumin improves in vitro cellular uptake and disruption of Poloxamer 407-based nanoparticles inside cancer cells.por
dc.identifier.issn15438384por
dc.identifier.urihttps://hdl.handle.net/1822/51753-
dc.description.abstractNovel nanoparticles based on Poloxamer 407 and vegetable oil were produced by high pressure homogenization. Functionalization of those nanoparticles was made by incorporation of folic acid (FA)-Poloxamer 407 conjugate. These nanoparticles showed suitable characteristics for intravenous therapeutic applications similarly to PEGylated albumin-based nanoparticles, previously described by our research group. Here, we found that the absence of albumin at the interface of Poloxamer 407-based nanoparticles improves the overall process of in vitro cellular uptake and nanoparticles disruption inside cancer cells (folate receptor, FR, positive cells). The results present here suggests that interfacial composition of those nanoparticles is of paramount importance for drug trafficking inside cancer cells.por
dc.description.sponsorshipThis study was supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER-006684) and BioTecNorte operation (NORTE-01-0145-FEDER-000004) funded by European Regional Development Fund under the scope of Norte2020Programa Operacional Regional do Norte. This work has received funding from the European Union Horizon 2020 research and innovation program under Grant Agreement NMP-06-2015-683356 FOLSMART. Diana Soares da Costa thanks Portuguese Foundation for Science and Technology (FCT) for funding her scholarship SFRH/BPD/85790/2012.por
dc.language.isoengpor
dc.publisherAmerican Chemical Societypor
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147337/PTpor
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/683356/EUpor
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F85790%2F2012/PTpor
dc.rightsopenAccesspor
dc.subjectfolic acid-Poloxamer 407 conjugatepor
dc.subjectfolic acid-Poloxamer 407 nanoparticlespor
dc.subjectnanoparticle disruptionpor
dc.subjectspecific drug releasepor
dc.subjectcancer therapypor
dc.titleThe absence of albumin improves in vitro cellular uptake and disruption of Poloxamer 407-based nanoparticles inside cancer cellspor
dc.typearticle-
dc.peerreviewedyespor
dc.relation.publisherversionhttp://pubs.acs.org/journal/mpohbppor
dc.commentsCEB47371por
oaire.citationStartPage527por
oaire.citationEndPage535por
oaire.citationIssue2por
oaire.citationConferencePlaceUnited States-
oaire.citationVolume15por
dc.date.updated2018-02-26T11:31:47Z-
dc.identifier.eissn1543-8382por
dc.identifier.doi10.1021/acs.molpharmaceut.7b00893por
dc.identifier.pmid29291347por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
dc.subject.wosScience & Technologypor
sdum.journalMolecular Pharmaceuticspor
Aparece nas coleções:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_47371_1.pdf3,92 MBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID